Skip to main content
Top
Published in: Journal of General Internal Medicine 4/2014

01-04-2014 | Multimorbidity Symposium

A Framework for Crafting Clinical Practice Guidelines that are Relevant to the Care and Management of People with Multimorbidity

Authors: Katrin Uhlig, MS, MD, Bruce Leff, MD, David Kent, MD, Cm, MSc, Sydney Dy, MD, MSc, Klara Brunnhuber, MD, Jako S. Burgers, MD, PhD, Sheldon Greenfield, MD, Gordon Guyatt, MD, MSc, Kevin High, MD, Rosanne Leipzig, MD, PhD, Cynthia Mulrow, MD, MSc, Kenneth Schmader, MD, Holger Schunemann, MD, MSc, PhD, Louise C. Walter, MD, James Woodcock, PhD, MSc, BA(Hons), Cynthia M. Boyd, MD, MPH

Published in: Journal of General Internal Medicine | Issue 4/2014

Login to get access

ABSTRACT

Many patients of all ages have multiple conditions, yet clinicians often lack explicit guidance on how to approach clinical decision-making for such people. Most recommendations from clinical practice guidelines (CPGs) focus on the management of single diseases, and may be harmful or impractical for patients with multimorbidity. A major barrier to the development of guidance for people with multimorbidity stems from the fact that the evidence underlying CPGs derives from studies predominantly focused on the management of a single disease. In this paper, the investigators from the Improving Guidelines for Multimorbid Patients Study Group present consensus-based recommendations for guideline developers to make guidelines more useful for the care of people with multimorbidity. In an iterative process informed by review of key literature and experience, we drafted a list of issues and possible approaches for addressing important coexisting conditions in each step of the guideline development process, with a focus on considering relevant interactions between the conditions, their treatments and their outcomes. The recommended approaches address consideration of coexisting conditions at all major steps in CPG development, from nominating and scoping the topic, commissioning the work group, refining key questions, ranking importance of outcomes, conducting systematic reviews, assessing quality of evidence and applicability, summarizing benefits and harms, to formulating recommendations and grading their strength. The list of issues and recommendations was reviewed and refined iteratively by stakeholders. This framework acknowledges the challenges faced by CPG developers who must make complex judgments in the absence of high-quality or direct evidence. These recommendations require validation through implementation, evaluation and refinement.
Literature
1.
go back to reference Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37–43.PubMedCrossRef Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380(9836):37–43.PubMedCrossRef
2.
go back to reference Patient-centered care for older adults with multiple chronic conditions: a stepwise approach from the american geriatrics society: american geriatrics society expert panel on the care of older adults with multimorbidity. J Am Geriatr Soc. 2012;60(10):1957–68. Patient-centered care for older adults with multiple chronic conditions: a stepwise approach from the american geriatrics society: american geriatrics society expert panel on the care of older adults with multimorbidity. J Am Geriatr Soc. 2012;60(10):1957–68.
3.
go back to reference Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351(27):2870–4.PubMedCrossRef Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351(27):2870–4.PubMedCrossRef
4.
go back to reference Fabbri LM, Boyd C, Boschetto P, Rabe KF, Buist AS, Yawn B, et al. How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc. 2012;9(5):274–81.PubMedCrossRef Fabbri LM, Boyd C, Boschetto P, Rabe KF, Buist AS, Yawn B, et al. How to integrate multiple comorbidities in guideline development: article 10 in Integrating and coordinating efforts in COPD guideline development. An official ATS/ERS workshop report. Proc Am Thorac Soc. 2012;9(5):274–81.PubMedCrossRef
5.
go back to reference Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294(6):716–24.PubMedCrossRef Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294(6):716–24.PubMedCrossRef
6.
go back to reference Schoen C, Osborn R, Doty MM, Bishop M, Peugh J, Murukutla N. Toward higher-performance health systems: adults’ health care experiences in seven countries, 2007. Health Aff (Millwood). 2007;26(6):w717–34.CrossRef Schoen C, Osborn R, Doty MM, Bishop M, Peugh J, Murukutla N. Toward higher-performance health systems: adults’ health care experiences in seven countries, 2007. Health Aff (Millwood). 2007;26(6):w717–34.CrossRef
7.
go back to reference Lugtenberg M, Burgers JS, Clancy C, Westert GP, Schneider EC. Current guidelines have limited applicability to patients with comorbid conditions: a systematic analysis of evidence-based guidelines. PLoS ONE. 2011;6(10):e25987.PubMedCentralPubMedCrossRef Lugtenberg M, Burgers JS, Clancy C, Westert GP, Schneider EC. Current guidelines have limited applicability to patients with comorbid conditions: a systematic analysis of evidence-based guidelines. PLoS ONE. 2011;6(10):e25987.PubMedCentralPubMedCrossRef
8.
go back to reference Brown AF, Mangione CM, Saliba D, Sarkisian CA. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51(5 Suppl Guidelines):S265–80.PubMed Brown AF, Mangione CM, Saliba D, Sarkisian CA. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51(5 Suppl Guidelines):S265–80.PubMed
9.
go back to reference Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuunemann HJ. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):7S–47S.PubMedCentralPubMedCrossRef Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuunemann HJ. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):7S–47S.PubMedCentralPubMedCrossRef
10.
go back to reference Department of Health and Human Services Strategic Framework on Multiple Chronic Conditions, 2010. Department of Health and Human Services Strategic Framework on Multiple Chronic Conditions, 2010.
12.
go back to reference Van Spall HG, Toren A, Kiss A, Fowler RA. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA. 2007;297(11):1233–40.PubMedCrossRef Van Spall HG, Toren A, Kiss A, Fowler RA. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA. 2007;297(11):1233–40.PubMedCrossRef
13.
go back to reference Nouwen A, Winkley K, Twisk J, Lloyd CE, Peyrot M, Ismail K, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia. 2010;53(12):2480–6.PubMedCentralPubMedCrossRef Nouwen A, Winkley K, Twisk J, Lloyd CE, Peyrot M, Ismail K, et al. Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis. Diabetologia. 2010;53(12):2480–6.PubMedCentralPubMedCrossRef
14.
go back to reference Braithwaite RS, Fiellin D, Justice AC. The payoff time: a flexible framework to help clinicians decide when patients with comorbid disease are not likely to benefit from practice guidelines. Med Care. 2009;47(6):610–7.PubMedCentralPubMedCrossRef Braithwaite RS, Fiellin D, Justice AC. The payoff time: a flexible framework to help clinicians decide when patients with comorbid disease are not likely to benefit from practice guidelines. Med Care. 2009;47(6):610–7.PubMedCentralPubMedCrossRef
15.
go back to reference Braithwaite RS, Concato J, Chang CC, Roberts MS, Justice AC. A framework for tailoring clinical guidelines to comorbidity at the point of care. Arch Intern Med. 2007;167(21):2361–5.PubMedCentralPubMedCrossRef Braithwaite RS, Concato J, Chang CC, Roberts MS, Justice AC. A framework for tailoring clinical guidelines to comorbidity at the point of care. Arch Intern Med. 2007;167(21):2361–5.PubMedCentralPubMedCrossRef
18.
go back to reference Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM. Patterns of functional decline at the end of life. JAMA. 2003;289(18):2387–92.PubMedCrossRef Lunney JR, Lynn J, Foley DJ, Lipson S, Guralnik JM. Patterns of functional decline at the end of life. JAMA. 2003;289(18):2387–92.PubMedCrossRef
19.
go back to reference Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ. What is "quality of evidence" and why is it important to clinicians? BMJ. 2008;336(7651):995–8.PubMedCentralPubMedCrossRef Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ. What is "quality of evidence" and why is it important to clinicians? BMJ. 2008;336(7651):995–8.PubMedCentralPubMedCrossRef
20.
go back to reference Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6.PubMedCentralPubMedCrossRef Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924–6.PubMedCentralPubMedCrossRef
21.
go back to reference Schunemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A, et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med. 2006;174(5):605–14.PubMedCrossRef Schunemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A, et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med. 2006;174(5):605–14.PubMedCrossRef
22.
go back to reference Barton MB, Miller T, Wolff T, Petitti D, LeFevre M, Sawaya G, et al. How to read the new recommendation statement: methods update from the U.S. Preventive Services Task Force. Ann Intern Med. 2007;147(2):123–7.PubMedCrossRef Barton MB, Miller T, Wolff T, Petitti D, LeFevre M, Sawaya G, et al. How to read the new recommendation statement: methods update from the U.S. Preventive Services Task Force. Ann Intern Med. 2007;147(2):123–7.PubMedCrossRef
23.
go back to reference Petitti DB, Teutsch SM, Barton MB, Sawaya GF, Ockene JK, DeWitt T. Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence. Ann Intern Med. 2009;150(3):199–205.PubMedCrossRef Petitti DB, Teutsch SM, Barton MB, Sawaya GF, Ockene JK, DeWitt T. Update on the methods of the U.S. Preventive Services Task Force: insufficient evidence. Ann Intern Med. 2009;150(3):199–205.PubMedCrossRef
24.
go back to reference Owens DK, Lohr KN, Atkins D, Treadwell JR, Reston JT, Bass EB, et al. AHRQ Series Paper 5: grading the strength of a body of evidence when comparing medical interventions—Agency for Healthcare Research and Quality and the Effective Health-Care Program. J Clin Epidemiol. 2010;63(5):513–23.PubMedCrossRef Owens DK, Lohr KN, Atkins D, Treadwell JR, Reston JT, Bass EB, et al. AHRQ Series Paper 5: grading the strength of a body of evidence when comparing medical interventions—Agency for Healthcare Research and Quality and the Effective Health-Care Program. J Clin Epidemiol. 2010;63(5):513–23.PubMedCrossRef
25.
go back to reference Institute of Medicine. Clinical Practice Guidelines We Can Trust: The National Academies Press, 2011. Institute of Medicine. Clinical Practice Guidelines We Can Trust: The National Academies Press, 2011.
26.
go back to reference National Institute for Clinical Excellence. Guideline Development Methods: Information for National Collaborating Centres and Guideline Developers. London: National Institute for Clinical Excellence; 2004. Updated 2005. National Institute for Clinical Excellence. Guideline Development Methods: Information for National Collaborating Centres and Guideline Developers. London: National Institute for Clinical Excellence; 2004. Updated 2005.
28.
go back to reference Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, Rodriguez RA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005;40(11):1559–85.PubMedCrossRef Gupta SK, Eustace JA, Winston JA, Boydstun II, Ahuja TS, Rodriguez RA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005;40(11):1559–85.PubMedCrossRef
29.
go back to reference KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007;49(2 Suppl 2):S12–154. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007;49(2 Suppl 2):S12–154.
30.
go back to reference Guyatt G, Akl EA, Hirsh J, Kearon C, Crowther M, Gutterman D, et al. The vexing problem of guidelines and conflict of interest: a potential solution. Ann Intern Med. 2010;152(11):738–41.PubMedCrossRef Guyatt G, Akl EA, Hirsh J, Kearon C, Crowther M, Gutterman D, et al. The vexing problem of guidelines and conflict of interest: a potential solution. Ann Intern Med. 2010;152(11):738–41.PubMedCrossRef
31.
32.
go back to reference Parker MG, Atkins MB, Ucci AA, Levey AS. Rapidly progressive glomerulonephritis after immunotherapy for cancer. J Am Soc Nephrol. 1995;5(10):1740–4.PubMed Parker MG, Atkins MB, Ucci AA, Levey AS. Rapidly progressive glomerulonephritis after immunotherapy for cancer. J Am Soc Nephrol. 1995;5(10):1740–4.PubMed
33.
go back to reference Giovannetti ER, Wolff JL, Xue QL, Weiss CO, Leff B, Boult C, et al. Difficulty assisting with health care tasks among caregivers of multimorbid older adults. J Gen Intern Med. 2012;27(1):37–44.PubMedCentralPubMedCrossRef Giovannetti ER, Wolff JL, Xue QL, Weiss CO, Leff B, Boult C, et al. Difficulty assisting with health care tasks among caregivers of multimorbid older adults. J Gen Intern Med. 2012;27(1):37–44.PubMedCentralPubMedCrossRef
34.
go back to reference Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med. 2006;354(4):379–86.PubMedCrossRef Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med. 2006;354(4):379–86.PubMedCrossRef
35.
go back to reference Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64(4):395–400.PubMedCrossRef Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64(4):395–400.PubMedCrossRef
36.
go back to reference KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009(113):S1–130. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009(113):S1–130.
37.
go back to reference Rahn DD, Abed H, Sung VW, Matteson KA, Rogers RG, Morrill MY, et al. Systematic review highlights difficulty interpreting diverse clinical outcomes in abnormal uterine bleeding trials. J Clin Epidemiol. 2011;64(3):293–300.PubMedCentralPubMedCrossRef Rahn DD, Abed H, Sung VW, Matteson KA, Rogers RG, Morrill MY, et al. Systematic review highlights difficulty interpreting diverse clinical outcomes in abnormal uterine bleeding trials. J Clin Epidemiol. 2011;64(3):293–300.PubMedCentralPubMedCrossRef
38.
go back to reference Legare F, Boivin A, van der Weijden T, Pakenham C, Burgers J, Legare J, et al. Patient and public involvement in clinical practice guidelines: a knowledge synthesis of existing programs. Med Dec Making. 2011;31(6):E45–74.CrossRef Legare F, Boivin A, van der Weijden T, Pakenham C, Burgers J, Legare J, et al. Patient and public involvement in clinical practice guidelines: a knowledge synthesis of existing programs. Med Dec Making. 2011;31(6):E45–74.CrossRef
39.
go back to reference den Breejen EM, Nelen WL, Knijnenburg JM, Burgers JS, Hermens RP, Kremer JA. Feasibility of a wiki as a participatory tool for patients in clinical guideline development. J Med Internet Res. 2012;14(5):e138.CrossRef den Breejen EM, Nelen WL, Knijnenburg JM, Burgers JS, Hermens RP, Kremer JA. Feasibility of a wiki as a participatory tool for patients in clinical guideline development. J Med Internet Res. 2012;14(5):e138.CrossRef
40.
go back to reference MacLean S, Mulla S, Akl EA, Jankowski M, Vandvik PO, Ebrahim S, et al. Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e1S–23S.PubMedCentralPubMed MacLean S, Mulla S, Akl EA, Jankowski M, Vandvik PO, Ebrahim S, et al. Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e1S–23S.PubMedCentralPubMed
41.
go back to reference Butler M, Talley KMC, Burns R, Ripley A, Rothman A, Johnson P, et al. Values of Older Adults Related to Primary and Secondary Prevention. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011. Butler M, Talley KMC, Burns R, Ripley A, Rothman A, Johnson P, et al. Values of Older Adults Related to Primary and Secondary Prevention. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011.
42.
go back to reference Sun X, Briel M, Busse JW, You JJ, Akl EA, Mejza F, et al. Credibility of claims of subgroup effects in randomised controlled trials: systematic review. BMJ. 2012;344:e1553.PubMedCrossRef Sun X, Briel M, Busse JW, You JJ, Akl EA, Mejza F, et al. Credibility of claims of subgroup effects in randomised controlled trials: systematic review. BMJ. 2012;344:e1553.PubMedCrossRef
43.
go back to reference Vollenweider D, Boyd CM, Puhan MA. High prevalence of potential biases threatens the interpretation of trials in patients with chronic disease. BMC Med. 2011;9:73.PubMedCentralPubMedCrossRef Vollenweider D, Boyd CM, Puhan MA. High prevalence of potential biases threatens the interpretation of trials in patients with chronic disease. BMC Med. 2011;9:73.PubMedCentralPubMedCrossRef
44.
go back to reference Boyd CM, Vollenweider D, Puhan MA. Informing evidence-based decision-making for patients with comorbidity: availability of necessary information in clinical trials for chronic diseases. PLoS One. 2012;7(8):e41601.PubMedCentralPubMedCrossRef Boyd CM, Vollenweider D, Puhan MA. Informing evidence-based decision-making for patients with comorbidity: availability of necessary information in clinical trials for chronic diseases. PLoS One. 2012;7(8):e41601.PubMedCentralPubMedCrossRef
45.
go back to reference Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 8. Rating the quality of evidence–indirectness. J Clin Epidemiol. 2011;64(12):1303–10.PubMedCrossRef Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 8. Rating the quality of evidence–indirectness. J Clin Epidemiol. 2011;64(12):1303–10.PubMedCrossRef
46.
go back to reference Guyatt GH, Helfand M, Kunz R. Comparing the USPSTF and GRADE approaches to recommendations. Ann Intern Med. 2009;151(5):363. author reply 63-4.PubMedCrossRef Guyatt GH, Helfand M, Kunz R. Comparing the USPSTF and GRADE approaches to recommendations. Ann Intern Med. 2009;151(5):363. author reply 63-4.PubMedCrossRef
47.
go back to reference Petitti DB, Teutsch SM, Barton MB, Sawaya GF, Ockene JK, DeWitt T. Comparing the USPSTF and GRADE Approaches to Recommendations. Ann Intern Med. 2009;151(5):363–64.CrossRef Petitti DB, Teutsch SM, Barton MB, Sawaya GF, Ockene JK, DeWitt T. Comparing the USPSTF and GRADE Approaches to Recommendations. Ann Intern Med. 2009;151(5):363–64.CrossRef
48.
go back to reference Kent DM, Hayward RA. Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. JAMA. 2007;298(10):1209–12.PubMedCrossRef Kent DM, Hayward RA. Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. JAMA. 2007;298(10):1209–12.PubMedCrossRef
49.
go back to reference Zulman DM, Sussman JB, Chen X, Cigolle CT, Blaum CS, Hayward RA. Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med. 2011;26(7):783–90.PubMedCentralPubMedCrossRef Zulman DM, Sussman JB, Chen X, Cigolle CT, Blaum CS, Hayward RA. Examining the evidence: a systematic review of the inclusion and analysis of older adults in randomized controlled trials. J Gen Intern Med. 2011;26(7):783–90.PubMedCentralPubMedCrossRef
50.
go back to reference Leipzig RM, Whitlock EP, Wolff TA, Barton MB, Michael YL, Harris R, et al. Reconsidering the approach to prevention recommendations for older adults. Ann Intern Med. 2010;153(12):809–14.PubMedCrossRef Leipzig RM, Whitlock EP, Wolff TA, Barton MB, Michael YL, Harris R, et al. Reconsidering the approach to prevention recommendations for older adults. Ann Intern Med. 2010;153(12):809–14.PubMedCrossRef
51.
go back to reference Trikalinos TA, Kulasingam S, Lawrence WF. Chapter 10: deciding whether to complement a systematic review of medical tests with decision modeling. J Gen Intern Med. 2012;27(Suppl 1):S76–82.PubMedCrossRef Trikalinos TA, Kulasingam S, Lawrence WF. Chapter 10: deciding whether to complement a systematic review of medical tests with decision modeling. J Gen Intern Med. 2012;27(Suppl 1):S76–82.PubMedCrossRef
52.
go back to reference You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang MC, et al. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e531S–75S.PubMedCentralPubMed You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang MC, et al. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e531S–75S.PubMedCentralPubMed
54.
go back to reference Greenfield S, Billimek J, Pellegrini F, Franciosi M, De Berardis G, Nicolucci A, et al. Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study. Ann Intern Med. 2009;151(12):854–60.PubMedCrossRef Greenfield S, Billimek J, Pellegrini F, Franciosi M, De Berardis G, Nicolucci A, et al. Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study. Ann Intern Med. 2009;151(12):854–60.PubMedCrossRef
55.
go back to reference Justice AC, McGinnis KA, Skanderson M, Chang CC, Gibert CL, Goetz MB, et al. Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers. HIV Med. 2010;11(2):143–51.PubMedCentralPubMedCrossRef Justice AC, McGinnis KA, Skanderson M, Chang CC, Gibert CL, Goetz MB, et al. Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers. HIV Med. 2010;11(2):143–51.PubMedCentralPubMedCrossRef
56.
go back to reference Minne L, Ludikhuize J, de Rooij SE, Abu-Hanna A. Characterizing predictive models of mortality for older adults and their validation for use in clinical practice. J Am Geriatr Soc. 2011;59(6):1110–5.PubMedCrossRef Minne L, Ludikhuize J, de Rooij SE, Abu-Hanna A. Characterizing predictive models of mortality for older adults and their validation for use in clinical practice. J Am Geriatr Soc. 2011;59(6):1110–5.PubMedCrossRef
57.
59.
go back to reference Kent DM, Rothwell PM, Ioannidis JP, Altman DG, Hayward RA. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials. 2010;11:85.PubMedCentralPubMedCrossRef Kent DM, Rothwell PM, Ioannidis JP, Altman DG, Hayward RA. Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal. Trials. 2010;11:85.PubMedCentralPubMedCrossRef
60.
go back to reference Tinetti ME, McAvay GJ, Chang SS, Newman AB, Fitzpatrick AL, Fried TR, et al. Contribution of multiple chronic conditions to universal health outcomes. J Am Geriatr Soc. 2011;59(9):1686–91. Tinetti ME, McAvay GJ, Chang SS, Newman AB, Fitzpatrick AL, Fried TR, et al. Contribution of multiple chronic conditions to universal health outcomes. J Am Geriatr Soc. 2011;59(9):1686–91.
Metadata
Title
A Framework for Crafting Clinical Practice Guidelines that are Relevant to the Care and Management of People with Multimorbidity
Authors
Katrin Uhlig, MS, MD
Bruce Leff, MD
David Kent, MD, Cm, MSc
Sydney Dy, MD, MSc
Klara Brunnhuber, MD
Jako S. Burgers, MD, PhD
Sheldon Greenfield, MD
Gordon Guyatt, MD, MSc
Kevin High, MD
Rosanne Leipzig, MD, PhD
Cynthia Mulrow, MD, MSc
Kenneth Schmader, MD
Holger Schunemann, MD, MSc, PhD
Louise C. Walter, MD
James Woodcock, PhD, MSc, BA(Hons)
Cynthia M. Boyd, MD, MPH
Publication date
01-04-2014
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 4/2014
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-013-2659-y

Other articles of this Issue 4/2014

Journal of General Internal Medicine 4/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.